摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

L-三氟乙酰甘氨酸 | 383-70-0

中文名称
L-三氟乙酰甘氨酸
中文别名
N-(三氟乙酰基)甘氨酸
英文名称
TFA-Gly
英文别名
2-(2,2,2-trifluoroacetamido)acetic acid;N-(Trifluoroacetyl)aminoacetic acid;2-[(2,2,2-trifluoroacetyl)amino]acetic acid
L-三氟乙酰甘氨酸化学式
CAS
383-70-0
化学式
C4H4F3NO3
mdl
MFCD00029784
分子量
171.076
InChiKey
IFAXXCBMQJNCCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120-121 °C
  • 沸点:
    291.6°C
  • 密度:
    1.534
  • 闪点:
    130°C
  • 溶解度:
    可溶于氯仿、二甲基亚砜

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2924199090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8℃

SDS

SDS:ea8fbeff6450a5128d84e3391735f5cb
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N-(Trifluoroacetyl)glycine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: N-(Trifluoroacetyl)glycine
CAS number: 383-70-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C4H4F3NO3
Molecular weight: 171.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

TFA-Gly-OH是一种甘酸(HY-Y0966)的衍生物

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    L-三氟乙酰甘氨酸氯化亚砜 作用下, 反应 1.17h, 以94%的产率得到(2,2,2-trifluoro-acetylamino)-acetyl chloride
    参考文献:
    名称:
    RNA基础尿嘧啶分解代谢的立体化学
    摘要:
    哺乳动物酶系统已用于研究嘧啶尿嘧啶(1)分解为氨基酸β-丙氨酸(4)的立体化学。在培养中使用[5- 2 H]-和[6- 2 H]-尿嘧啶和2 H 2 O产生β-丙氨酸的立体特异性氘化样品。测定法,涉及β丙氨酸在四个C-H键的氘明确地标记的样本的总合成已经显示的是,在分解代谢过程中的第一步,尿嘧啶是通过二氢脱氢酶降低与整体抗加入氢气,在SI在C-6面和SI面在C-5。
    DOI:
    10.1039/p19850001355
  • 作为产物:
    描述:
    聚甘氨酸四氢呋喃氯仿 、 Petroleum ether 为溶剂, 生成 L-三氟乙酰甘氨酸
    参考文献:
    名称:
    STRUCTURAL MIMETICS OF PROLINE-RICH PEPTIDES AND THEIR USE
    摘要:
    本发明提供了一个包含一般式1的化合物: 在一般式1中,X至少是O和S中的一个。A是一个环桥。Y1至少是H、烷基、氟烷基、芳基和杂环芳基中的一个。Z1、Z2、Z3分别或交替地至少是H、羰基、OH、O-烷基、O-酰基、N—R1R2(其中R1或R2分别或交替地至少是H、烷基、酰基和磺酰基中的一个)、烷基、酰基、氟烷基、芳基和杂环芳基中的一个。R1至少是烷基、酰基、烷氧羰基、芳氧羰基和氨基羰基中的一个。R2至少是H、烷基、芳基、烷基羰基、芳基羰基、烷氧羰基、氨基羰基、芳氧羰基、烷基磺酰基、芳基磺酰基、氨基酰基和肽基中的一个。本发明还涉及将该化合物用作药物活性化合物的用途,以及将药物活性化合物用于治疗细菌性疾病、神经退行性疾病和肿瘤的用途。
    公开号:
    US20140100217A1
  • 作为试剂:
    描述:
    4-碘代苯乙酮 、 3-[(3-Methoxyphenyl)methoxy]-1,3-dihydrofuro[3,4-b]quinoline 在 palladium(II) trifluoroacetate 、 L-三氟乙酰甘氨酸 、 2-carbomethoxynorbornene 、 silver(I) acetate 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 24.0h, 以66%的产率得到1-[4-[3-(1,3-Dihydrofuro[3,4-b]quinolin-3-yloxymethyl)-5-methoxyphenyl]phenyl]ethanone
    参考文献:
    名称:
    使用易于连接和可裂解的分子支架对芳香醇进行间位选择性 C−H 芳基化
    摘要:
    描述了基于芳烃醇的底物间位选择性 C-H 芳基化的第一个例子。该策略涉及将瞬时降冰片烯策略与基于喹啉的缩醛支架相结合,以实现联芳基化合物的形成。描述了两步元芳基化/支架裂解过程和完整的伸缩程序,强调了乙缩醛支架的附着、移除和恢复的便利属性。此外,间位芳基化化合物可以通过邻位选择性官能化进一步衍生化。这些过程为醇基化合物的催化多官能化奠定了基础。
    DOI:
    10.1002/chem.201703054
点击查看最新优质反应信息

文献信息

  • The <i>ortho</i>-substituent on 2,4-bis(trifluoromethyl)phenylboronic acid catalyzed dehydrative condensation between carboxylic acids and amines
    作者:Ke Wang、Yanhui Lu、Kazuaki Ishihara
    DOI:10.1039/c8cc02558d
    日期:——
    2,4-Bis(trifluoromethyl)phenylboronic acid is a highly effective catalyst for dehydrative amidation between carboxylic acids and amines. Mechanistic studies suggest that a 2 : 2 mixed anhydride is expected to be the only active species, and the ortho-substituent of boronic acid plays a key role in preventing the coordination of amines to the boron atom of the active species, thus accelerating the amidation
    2,4-双(三甲基)苯基硼酸是用于羧酸和胺之间的脱酰胺化的高效催化剂。机理研究表明,预计2:2混合酸酐是唯一的活性物质,硼酸的原取代基在防止胺与活性物质的原子配位方面起关键作用,从而促进酰胺化。该催化剂可用于α-二肽合成。
  • [EN] NOVEL COLCHICINE DERIVATIVES, METHODS AND USES THEREOF<br/>[FR] NOUVEAUX DÉRIVÉS DE COLCHICINE, LEURS PROCÉDÉS ET UTILISATIONS
    申请人:ALBERTA HEALTH SERVICES
    公开号:WO2011022805A1
    公开(公告)日:2011-03-03
    The invention relates to colchicine derivatives, methods and uses thereof for treatment of cancer. In certain embodiments, the colchicine derivative comprises a compound of formula (I), wherein Z is O or S; R1 is selected fro H, a halo group, a substituted or unsubstituted hydrocarbon group, or a substituted or unsubstituted heterogeneous group; R2 and R3 are each independently selected from H, a halo group, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aromatic, or a substituted or unsubstituted heteroaromatic; R is selected from H or a substituted or unsubstituted hydrocarbon group, with the proviso that when R, R2 and R3 are methyl groups, R1 is not -COCH3.
    本发明涉及秋水仙碱生物、其制备方法及其用于治疗癌症的应用。在某些实施例中,秋水仙碱生物包括公式(I)的化合物,其中Z是O或S;R1选自H、卤素基团、取代或不取代的烃基团或取代或不取代的杂原子基团;R2和R3各自独立地选自H、卤素基团、取代或不取代的烃基团、取代或不取代的杂原子基团、取代或不取代的碳环基团、取代或不取代的杂环基团、取代或不取代的芳香基团或取代或不取代的杂芳香基团;R选自H或取代或不取代的烃基团,但R、R2和R3为甲基基团时,R1不是-COCH3。
  • Effect of N-Trifluoroacetyl Derivatives of Amino Acids and Amino Acid Analogs on Microbial Antitumor Screen
    作者:Theodore T. Otani、Mary R. Briley
    DOI:10.1002/jps.2600680428
    日期:1979.4
    Eighteen trifluoroacetyl derivatives of amino acids and of amino acid analogs were prepared and tested for growth-inhibitory activity using a Lactobacillus casei system as a prescreen for antitumor activity. Of the compounds tested, the trifluoroacetyl derivatives of o-, m-, and p-fluorophenylalanine and of beta-3-thienylalanine showed modest activity; trifluoroacetyl derivatives of phenylalanine and of
    制备了十八种氨基酸氨基酸类似物的三氟乙酰基衍生物,并使用干酪乳杆菌系统作为抗肿瘤活性的预筛测试了其生长抑制活性。在所测试的化合物中,邻,间和对氟苯基丙酸和β-3-噻吩酸的三氟乙酰基衍生物显示出适度的活性。苯丙酸和β-2-噻吩酸的三氟乙酰基衍生物显示边缘活性。活性三氟乙酰基化合物表现出的活性与先前报道的大多数活性乙酰基衍生物所指出的活性相同,这是通过将它们与乙酰基-间-氟苯酸的活性进行比较来判断的。当这些抑制剂的代表用相应的天然代谢物挑战时,没有发现抑制作用的逆转,
  • [EN] PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF<br/>[FR] PROMÉDICAMENTS À BASE DE KÉTAMINE, COMPOSITIONS ET UTILISATIONS DE CEUX-CI
    申请人:XW LAB INC
    公开号:WO2019137381A1
    公开(公告)日:2019-07-18
    Provided are prodrugs of (S) -or (R) -ketamine, including isotopically labeled ketamine,composition and uses thereof. Compounds having formula (Ia) or (Ib) as the prodrugs of (S) -or (R) -ketamine, including isotopically labeled ketamine, and pharmaceutical compositions comprising the compounds provided herein are used for treating or preventing a CNS disease.More particularly, the related diseases include depression and pain. (Ia) (Ib)
    提供了(S)-或(R)-氯胺酮的前药,包括同位素标记的氯胺酮,其组成和用途。具有化学式(Ia)或(Ib)的化合物作为(S)-或(R)-氯胺酮的前药,包括同位素标记的氯胺酮,以及包含本文提供的化合物的药物组合物用于治疗或预防中枢神经系统疾病。更具体地,相关疾病包括抑郁症和疼痛。(Ia)(Ib)
  • Synthesis, spectroscopic and magnetic properties of nickel(II) with N-protected amino acids: crystal and molecular structure of bis(N-acetylglycinato)tetraaquonickel(II)
    作者:S.S. Sandhu、M.S. Hundal、Geeta Sood、S.S. Dhillon
    DOI:10.1016/s0277-5387(00)86531-6
    日期:1989.1
    Abstract Nickel(II) complexes of the general formula NiL2·nH2O have been prepared with various N-protected amino acids and characterized by thermogravimetric, magnetic susceptibility, IR and UV spectroscopy. The crystal structure of bis(N-acetylglycinato) tetraaquonickel(II) has been determined. The coordination around nickel is octahedral with two acetylglycine ligands trans to each other. Acetylglycine
    摘要用各种N-保护的氨基酸制备了通式为NiL2·nH2O的(II)配合物,并通过热重,磁化率,红外和紫外光谱进行了表征。已经确定了双(N-乙酰基乙酸)四季(II)的晶体结构。周围的配位是八面体,两个乙酰基甘配体彼此反过来。乙酰甘酸通过一个羧基的氧与配位,其余四个配位位点被四个分子占据。该结构通过强分子间氢键结合在一起。光谱研究表明,所有复合物的结构均为八面体。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸